Santen Pharmaceutical Co., Ltd.Santen Pharmaceutical Co., Ltd.Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co., Ltd.

No trades
See on Supercharts

SNPHY fundamentals

Santen Pharmaceutical Co., Ltd. key financial stats and ratios

SNPHY price-to-sales ratio is 2.12. The company has an Enterprise Value to EBITDA ratio of 8.08. As of 2023 they employed 3.74 k people.

Statistics
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Price to earnings ratio
Price to cash flow ratio
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Current
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios